Anika Therapeutics | ANIK - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
Abbott USD 2.13B 281M 2026-06
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Ligand Pharmaceuticals USD 60.33M 40.29M 2026-03
MacroGenics USD -33.44M 21.34M 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 1.94B 239M 2026-03
Smith & Nephew USD 440M 50M 2025-12
Stryker USD 1.1B 867M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Xencor USD -77.86M 24.23M 2026-03
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03